Related Experiment Video

Updated: Jul 29, 2026

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
09:19

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies

Published on: January 4, 2015

Novel gene therapeutic strategies for neurodegenerative diseases

K A Maguire-Zeiss1, H J Federoff

  • 1Center for Aging and Developmental Biology, University of Rochester, School of Medicine and Dentistry, NY 14642, USA. Kathleen_maguirezeiss@urmc.rochester.edu

Ernst Schering Research Foundation Workshop
|December 1, 2005
PubMed

Insights

Parkinson's disease (PD) may stem from various triggers converging on a common cell death pathway. Combination therapies targeting this pathway, alongside early detection via neuroimaging and pharmacogenomics, offer the most promising treatment strategies.

Area of Science:

  • Neuroscience
  • Pathobiology
  • Pharmacology

Background:

  • Parkinson's disease (PD) pathogenesis is complex, with evidence suggesting diverse initial insults converge on shared cellular mechanisms.
  • Understanding these convergent pathways is crucial for developing effective therapeutic interventions.

Purpose of the Study:

  • To elucidate the convergent pathobiologic model of Parkinson's disease.
  • To highlight the potential of combinatorial treatments targeting shared pathways in PD.

Main Methods:

  • Review of current understanding of PD pathobiology.
  • Analysis of emerging neuroimaging and pharmacogenomic technologies for early detection.
  • Discussion of advancements in pharmacology, neurosurgery, and gene therapy.

Main Results:

  • The convergent pathobiologic model provides a framework for understanding PD initiation and progression.
  • Early detection of sporadic PD is becoming feasible through technological advancements.
  • Combinatorial therapies targeting common pathways show significant therapeutic potential.

Conclusions:

  • A unified pathway model supports the development of targeted, combination therapies for Parkinson's disease.
  • Early diagnosis and intervention are key to preserving dopaminergic neurons and improving patient outcomes.
  • Future advancements in multiple therapeutic modalities will enhance the management of Parkinson's disease.

More Related Videos

Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector08:33

Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector

Published on: February 28, 2016

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice04:41

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

Published on: February 24, 2026

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.